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What's new? 
 Diabetic retinopathy screening is effective but uptake is sub-optimal. 
 Theoretical determinants (barriers and enablers) of screening attendance were 
identified that operate at the level of the person with diabetes (e.g. confusion between 
retinopathy screening and routine eye care), the healthcare professionals (e.g. lack of 
recommendation to screen), the healthcare system (e.g. inaccurate registers), and the 
wider community (e.g. lack of media coverage). 
 Findings from this study will help to inform which theoretical determinants to target 
in interventions that seek to improve attendance at diabetic retinopathy screening. 
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Abstract  
Aims To identify and synthesize studies reporting modifiable barriers/enablers associated 
with retinopathy screening attendance in people with Type 1 or Type 2 diabetes, and to 
identify those most likely to influence attendance. 
Methods We searched MEDLINE, EMBASE, PsycINFO, Cochrane Library and the 'grey 
literature' for quantitative and qualitative studies to February 2017. Data (i.e. participant 
quotations, interpretive summaries, survey results) reporting barriers/enablers were extracted 
and deductively coded into domains from the Theoretical Domains Framework; with domains 
representing categories of theoretical barriers/enablers proposed to mediate behaviour 
change. Inductive thematic analysis was conducted within domains to describe the role each 
domain plays in facilitating or hindering screening attendance. Domains that were more 
frequently coded and for which more themes were generated were judged more likely to 
influence attendance.  
Results Sixty-nine primary studies were included. We identified six theoretical domains 
[‘environmental context and resources’ (75% of included studies), ‘social influences’ (51%), 
‘knowledge’ (50%), ‘memory, attention, decision processes’ (50%), ‘beliefs about 
consequences’ (38%) and ‘emotions’ (33%)] as the key mediators of diabetic retinopathy 
screening attendance. Examples of barriers populating these domains included inaccurate 
diabetic registers and confusion between routine eye care and retinopathy screening. 
Recommendations by healthcare professionals and community-level media coverage acted as 
enablers.  
Conclusions Across a variety of contexts, we found common barriers to and enablers of 
retinopathy screening that could be targeted in interventions aiming to increase screening 
attendance. 
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Introduction  
Diabetic retinopathy is a leading cause of severe sight loss in people of working age [1,2]. 
Although effective treatments are available [3], their success is dependent on early detection 
and timely referral. Diabetic retinopathy screening effectively reduces risk of sight loss; 
however, screening attendance is consistently below recommended levels [4–6]. 
 
Interventions that target screening behaviour are more likely to be effective if they address 
the determinants (barriers and enablers) of screening attendance. The Theoretical Domains 
Framework of behaviour change [7] proposes 14 ‘theoretical domains’ for identifying and 
categorizing barriers/enablers (e.g. ‘knowledge,’ ‘beliefs about consequences,’ ‘social 
influences’). Each domain represents a set of related constructs that may mediate behaviour 
change. For example, the ‘social influences’ domain includes the constructs ‘social support,’ 
‘group norms’ and ‘social comparison’ [8]. The framework thus provides a theory-driven 
basis for investigating the potentially wide-ranging barriers to/enablers of behaviour change.
 
 
The Theoretical Domains Framework has been applied in numerous studies to identify and 
characterize systematically barriers to/enablers of implementation across various clinical 
contexts, primarily through interview and survey studies. More recently the framework has 
been applied in systematic reviews of barriers/enablers, as a coding framework for data 
synthesis, for example, in a study of barriers to the optimal clinical management of stroke [9]. 
Identifying barriers/enablers in the literature, framing these in terms of theoretical domains, 
and identifying their likely importance for screening attendance, are steps that might explain 
why some interventions are more effective than others. This would enable intervention 
designers to optimize interventions by ensuring that they target the likely determinants of 
screening attendance. 
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We aimed to gain an understanding of diabetic retinopathy screening attendance behaviour by 
identifying the theoretical determinants of screening attendance. 
 
The specific objectives were to: identify the published and 'grey' literature reporting 
perceived barriers and enablers associated with screening attendance; extract reported 
barriers/enablers and categorize these according to Theoretical Domains Framework 
domains; and apply pre-specified criteria to identify the likely importance of Theoretical 
Domains Framework domains in influencing screening attendance.  
 
Methods  
A detailed protocol for this review has been published [10] and registered in PROSPERO 
(CRD42016032990). In brief, we included studies reporting primary data relating to 
modifiable factors that might hinder or facilitate retinopathy screening attendance. We 
included studies reported in English and conducted between January 1990 and February 
2017, basing the lower date limiter on the publication of the St Vincent Declaration 
('Diabetes care and research in Europe: the Saint Vincent declaration', 1990), which set a 
target to reduce new blindness in Europe by one-third or more, as this was arguably the 
catalyst for the development of diabetic retinopathy screening programmes worldwide. 
Studies were excluded if the reported barrier to screening was non-modifiable, for example, 
relating to age, gender, socio-economic status or duration of diabetes. 
Six bibliographic databases were searched to identify the published literature (MEDLINE, 
EMBASE, PsycINFO, Web-of-Science, CENTRAL in the Cochrane Library, Proquest). An 
example search strategy for MEDLINE is provided in Appendix S1. Grey literature databases 
were also searched (e.g. OpenGrey and PsycEXTRA), alongside a Google search engine 
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search using the terms: 'diabetic retinopathy' AND 'screening' AND [barrier* OR 'facilitat* 
OR enable]. We limited the Google search to the first 15 pages. Reference lists of included 
studies were screened for additional studies. After removal of duplicates, one member of the 
research team (E.G.R.) screened all identified titles and abstracts against the 
inclusion/exclusion criteria. A second review author (F.L.) rescreened 300 (10%) of the titles 
and abstracts to check reliability. Since the inter-rater agreement was substantial (Cohens κ= 
0.82) it was judged unlikely that double-checking further papers would have had a material 
impact on the level of agreement. Full-text copies of potentially eligible studies were 
obtained and a final decision was made on inclusion by consensus amongst the review team.  
 
Data extraction and analysis  
We followed analysis methods used in previous studies applying the Theoretical Domains 
Framework to interview transcripts from semi-structured interviews [11]. These methods 
follow a combined content and framework analysis approach (Fig. 1) involving four steps: 1) 
data extraction; 2) deductive analysis (Theoretical Domains Framework coding); 3) inductive 
analysis (thematic synthesis); and 4) identifying important domains. 
 
Step 1: Data extraction  
One review author (E.G.R.) identified and extracted data reporting participants’ [e.g. people 
with diabetes and/or healthcare professionals (HCPs)] perceptions of modifiable barriers/ 
enablers associated with screening attendance. A second reviewer (J.G.L.) checked the 
accuracy of data extraction on a random 20% sample of included studies. Extracted data 
included participant quotations from qualitative studies, quantitative findings from 
questionnaire and survey studies and authors’ interpretive descriptions and summaries of 
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results. Predictors of and associations with attendance/non-attendance reported in quantitative 
studies were also extracted. 
 
Step 2a: Pilot coding exercise 
In order to practise coding extracted data into theoretical domains, three pilot transcripts were 
coded independently by two reviewers (E.G.R. and F.L.). Any discrepancies were discussed 
until agreement was reached. The pilot transcripts were used to develop a Theoretical 
Domains Framework codebook (the content of the codebook is provided in Appendix S2). 
 
Step 2b: Theoretical Domains Framework coding 
One review author (E.G.R.) coded the data extracted from all remaining studies. Extracted 
data were coded according to which domain they were judged to represent, guided by the 
codebook. Using a process that was arguably more robust than the 20% double-coding 
specified in the study protocol [10], three members of the review team (E.G.R., F.L., J.J.F.) 
met to verify and discuss every extracted data item to assess the domain-level coding, in the 
context of step 3 (described below).  
 
Step 3: Thematic synthesis  
In line with a framework analysis approach, step 3 focused on sifting and sorting the data 
within each domain to synthesize thematically and identify emerging content themes. One 
review author (E.G.R.) grouped together similar data relating to perceived barriers 
of/enablers to screening attendance, for each of the 14 domains. Theme labels (describing 
broad content themes) and, where appropriate, sub-theme labels (nested within the themes, 
describing more detailed content) were then generated for each cluster of similar data to 
express these shared views. Three members of the review team (E.G.R., F.L., J.J.F.) met to 
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verify and discuss every extracted data item to assess: 1) their agreement with grouping of 
extracted data; 2) their agreement with assigned theme and sub-theme labels; and 3) whether 
the theme was appropriately allocated to the given domain. Disagreements were discussed 
until consensus was reached, and theme groups, labels and allocation of domains were 
revised accordingly.  
 
Additionally, E.G.R. assigned the data within the themes as either representing barriers to or 
enablers of screening attendance. This was usually clear from the original papers as it was 
either reported in a table titled ‘barriers to’ or ‘enablers of screening attendance' or interpreted 
as one or the other by the study author. Each theme/sub-theme was then classified as: 1) a 
barrier theme if the data within it related to barriers only (e.g. receiving insufficient notice of 
appointments); 2) an enabler theme if the data within it related to enablers only (e.g. support 
from local community groups/networks); and 3) both a barrier and an enabler theme if it 
related to both [e.g. (in)flexibility of choice of times/dates of appointments]. 
 
Step 4: Identifying important domains 
Each domain identified in step 2 was reviewed against an established set of three ‘importance 
criteria’ [12] to determine which domains were likely to be important for influencing 
screening attendance: (1) frequency (number of studies that identified each domain; (2) 
elaboration (number of themes and sub-themes) within each domain; and (3) ‘expressed 
importance’ (either a statement from the authors’ interpretation or direct quotes from study 
participants expressing importance).  
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Quality assessment 
One review author (E.G.R.) rated included studies using items from the Critical Appraisal 
Skills Programme Qualitative Checklist (http://www.casp-uk.net/casp-tools-checklists) and 
the Mixed Methods Appraisal Tool 
(https://www.mcgill.ca/familymed/research/projects/mmat). Mixed-methods studies were 
appraised using both quantitative and qualitative appraisal tools. A second review author 
(J.L.) independently assessed a random sample of studies (20%). Agreement was not 
formally assessed, but only minor differences of opinion regarding study quality were 
identified and resolved by discussion.  
 
Results  
Study characteristics  
After removing duplicates, we screened 3194 studies and reviewed 234 full-text articles. We 
excluded 165 studies with reasons and included 69 studies that met our inclusion criteria (Fig. 
2). Table 1 presents an overview of the characteristics of included studies. Full details of the 
included studies are provided in Appendix S3 and a list of excluded studies can be found in 
Appendix S8. 
 
Quality of included studies  
The studies were judged to be at low (46.7%), medium (8.3%) or unclear (45%) risk of bias 
(Appendix S4). 
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Deductive analysis  
In total, 737 units of data were extracted: 468 qualitative (167 quotations from study 
participants and 301 from authors’ conclusions) and 269 quantitative units (e.g. percentages 
of participants agreeing with a questionnaire item, or odds ratios).  
 
Reported barriers were identified in all but one of the theoretical domains (‘skills’). Enablers 
were identified in all but two domains (‘beliefs about capabilities’ and ‘skills’). Overall, there 
were almost twice as many themes/sub-themes identified as barriers only than as enablers 
only (62 vs 35). Twenty-one themes/subthemes represented both barriers/enablers. Table 2 
reports the frequencies of barriers/enablers identified within each domain. 
 
Inductive analysis 
Appendix S5 presents all themes and sub-themes identified within each domain, alongside 
frequencies, relevant studies and sample quotations. A narrative description of the themes, 
within domains, is presented below, for the domains that were identified as high in 
importance. 
 
Importance of Theoretical Domains Framework domains 
Domain frequency 
The data units were coded most frequently into the following domains: 1) environmental 
context and resources (52 studies); 2) social influences (35 studies); 3) knowledge (35 
studies); 4) memory, attention and decision processes (34 studies); 5) beliefs about 
consequences (26 studies); and 6) emotions (23 studies).  
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Level of elaboration 
Approximately 82% of themes/sub-themes relating to barriers and 69% relating to enablers 
were captured in the same six theoretical domains (Table 2). Table 3 lists the numbers of 
themes and sub-themes identified within each domain. 
 
Rank order of domain importance  
In Table 3, the 14 theoretical domains are presented in rank order. In general, there was good 
convergence between frequency (number of studies in which the domain was evident) and 
elaboration (number of themes and sub-themes based on the inductive analysis).  
 
Expressed importance 
Study authors’ interpretations of the study findings (e.g. in Discussion sections) articulating 
specific beliefs as important influences, also provided evidence of the importance of barriers/ 
enablers. Quotations expressing importance are presented in Appendix S7, alongside the 
domain they were judged to represent. For example, the following quotations from included 
studies represent expressed importance for the domain: 1) ‘environmental context and 
resources’ ('Getting to and from screening appointment was important pragmatically for 
many patients, who had to overcome a range of issues') and 2) ‘beliefs about consequences’ 
('The main reason for refusal was the retinal photos taken might worsen sight'). The number 
of studies that identified each domain through expressed importance was counted: the higher 
the count, the higher the expressed importance. On this basis, important domains were: 
environmental context and resources (21 studies); knowledge (19 studies); memory attention 
and decision processes (12 studies); social influences (10 studies); beliefs about 
consequences (six studies); and emotions (five studies). This list corresponds well with the 
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list of six domains of high importance identified by the importance criteria ‘frequency’ and 
‘elaboration’ (Table 3).  
 
In summary, there was good convergence between all three criteria for identifying the 
importance of six theoretical domains, suggesting these domains are likely to be key 
mediators of screening attendance behaviour.  
 
Thematic synthesis for domains identified as having high importance 
The content themes in the domains that were identified as potentially important factors 
influencing screening attendance are described in further detail in the sections below, with 
example references.  
 
Environmental context and resources (52 studies) 
Theme: Accessibility to the screening clinic (31 studies). The theme of accessibility to the 
screening clinic was identified by both people with diabetes and HCPs. 'Accessibility' 
included issues with transport (e.g. lack/cost/poor quality) and distance to the screening 
clinic. In one correlational study, in an urban area, attendance was associated with living 
within an eight-mile radius of the screening facility and with access to public transport [13]. 
In several studies, distance from home to screening services was thought to improve 
attendance [14,15]. In two studies, mobile screening units were associated with higher 
attendance compared with screening appointments at high street optometrists [16,17]. 
 
Theme: Time (competing demands; 29 studies). People with diabetes often cited time 
constraints as a barrier to attendance. Competing demands on their time were attributable to: 
work commitments (e.g. finding it hard to take time off work); family responsibilities (e.g. 
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childcare); and clashes with other immoveable life events (e.g. holidays, religious/cultural 
activities. One HCP commented that: 'People go away…to the Caribbean, Africa, Asia, 
Pakistan, India… and because they’re away they’re not going to get their screening done' 
[18]. 
 
Themes: Financial concerns (27 studies) and consequences of private insurance (five 
studies). Financial concerns, such as the cost of the eye examination/care and the cost or lack 
of insurance were common, especially in the studies from the USA [19,20], but attendance 
was sometimes not influenced by insurance [21]. Self-employed or casual employees 
reported costs owing to lost income when they took time off work to attend screening 
appointments [22,23]. 
 
Theme: Scheduling appointment issues (19 studies). Problems with scheduling appointments, 
including a long wait to receive an appointment and inability to get an appointment, were 
barriers to attendance. Three UK studies mentioned that people with diabetes had not 
received an invitation or had been given insufficient notice [23–25]. Some expressed a 
preference for appointment flexibility but, in one study, older people with diabetes preferred 
fixed appointments [26]. Centrally allocated appointments were perceived by some HCPs to 
be problematic [15], as they undermined their own attempts to bring their patients to the 
clinic [18].  
 
Theme: Time (service issues; nine studies). Long waiting times on the day of the appointment 
and lengthy appointments were barriers to attendance. For multiple appointments some 
reported 'waiting around all day' [27], while long appointments could be especially 
problematic for people with diabetes, because of lengthy food abstinence [28]. 
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Theme: Referral issues (eight studies). The absence of a referral was a substantial problem 
for some. In one UK study, a person with diabetes who normally attended her screening 
appointments had attempted to access screening through her general practice but was refused 
as she was in temporary accommodation waiting to be rehoused [28]. In some countries, 
people with diabetes were not referred because there was no available eye doctor [14]. 
Inaccurate or incomplete registers could also result in lack of referral [15,18]. 
 
Theme: Specialist diabetes services and staff (six studies). The integration of specialist 
diabetes services or ‘one-stop-shops’ was viewed as beneficial: 'if the eye appointment was 
on the same day as the DM [diabetes mellitus] appointment I would definitely attend' [14]; 
however, inflexible or incompatible administration systems were a problem [18]. Having a 
specialist practice nurse was associated with increased attendance in two studies [16,29]. 
 
Social influences (35 studies)  
Theme: Doctor–patient communication (25 studies). Doctor–patient communication was 
discussed in many studies. A recommendation by the HCP to attend screening was an enabler 
[30,31], and having received a recommendation from a healthcare provider to attend 
screening was associated with attendance [32–34]. The absence of an HCP recommendation 
was a barrier in other studies [35–38]. Some people with diabetes reported lack of 
information provision from their healthcare providers [27,30,39], especially at the point of 
diagnosis. 
 
Language and/or communication style, especially for people whose first language was not the 
same as the HCP’s, was a barrier. In some studies people with diabetes reported language 
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difficulties as the primary reason for not attending screening appointments [24]. In one study 
a participant 'didn’t understand her physician and was too intimidated to ask him to slow 
down when conversing' and was unaware of the recommendation to attend [22]. In some 
studies, participants felt that systems were in place to overcome this barrier (e.g. provision of 
interpreters and accompanying family members) [15,28,40]; however, HCPs noted that 
accompanying relatives might not have the language skills needed to interpret correctly [15]. 
 
Theme: Trust in doctors (five studies). Advice and recommendations from doctors were 
perceived to be an enabler in several studies, and some people with diabetes were content to 
rely on their doctor’s advice regarding screening [30]; however, in one study, it was reported 
that a small number did not trust doctors [31] and another reported that low confidence in 
doctors was more common in non-attenders than attenders [34]. Perceived discrimination in 
the healthcare system was associated with longer time periods between screening visits [41]. 
Conversely, a study in a Canadian Aboriginal population reported that a culturally sensitive 
community-based clinic overcame such barriers [22]. 
 
Theme: Presence or absence of support from family members (11 studies). Family support, 
both practical (e.g. providing transport to the clinic) and emotional (e.g. encouragement, 
offering gentle reminders), was an enabler [30,31], and its absence was a barrier [42,43]. 
Family support was especially important in communities that traditionally rely on their family 
members to look after them [40] or when the person had a physical disability [38]. 
 
Theme: Encouragement/support from local community groups/networks (three studies) plus 
media attention and coverage (four studies). Community-based programmes fostered trust 
and support [22] and provided information [40,44]. Furthermore, local media (television, 
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newspapers, radio channels) had potential to raise awareness and promote attendance at 
screening, whereas lack of media attention could contribute to low attendance [28].  
 
Theme: Stigma (three studies). Some people with diabetes spoke of social stigma or shame 
being attached to a diabetes diagnosis [40,44]. HCPs also spoke about the difficulties of being 
confronted by a person’s perceptions of stigma [45].  
 
Knowledge (35 studies) 
Theme: (Lack of) awareness of illness (19 studies). Several studies reported that a lack of 
knowledge about diabetes, diabetic retinopathy and the link between the two was a barrier to 
attendance. An understanding of how diabetes can affect vision was an essential and 
motivating factor associated with attendance: 'If I had realised the possibility that I would 
suddenly go (blind), that I wouldn’t realise that it was coming on, I think I would have taken 
more care.' [46]. There was a significant association between believing diabetes could affect 
vision and attendance [43]. HCPs argued that some people with diabetes lack understanding 
of the link between diabetes and vision [23,47]; however, HCPs were not always happy to 
make the link clear, being careful not to alarm their patient: 'I would never say to someone 
that there is a possibility that you could go blind from diabetes' [46].  
 
Theme: (Lack of) awareness of screening (17 studies) and confusion between screening and 
routine eye tests (eight studies). Lack of awareness of the need to screen (including 
recommended frequency) was a barrier to attendance, and awareness was an enabler: 'On the 
one hand a group of over-65s had very little knowledge about why they attend for screening. 
They know it is important that they go, and so they keep the appointments but they did not 
know … that screening helped to prevent blindness' [15]. In one study, people with diabetes 
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who were not able to explain why diabetic retinopathy screening is needed reported more 
barriers than those who could [48]. Some were not aware of the difference between diabetic 
retinopathy screening and routine eye tests; hence, some believed they had attended screening 
when they had not [24,28,33]. 
 
Theme: Education and training (eight studies). Receiving diabetes self-management or 
blindness prevention classes significantly increased attendance [20,49,50], whilst those who 
had not received education on diabetes care were screened significantly less often than those 
who had [51]. 
 
Memory, attention and decision processes (34 studies) 
Theme: Symptoms (24 studies). The absence of symptoms often resulted in people with 
diabetes deciding not to attend screening [15,23,38,44,52]. This barrier was evident across 
different countries and screening contexts (e.g. UK, USA, Africa, Asia and Australia) and 
may be especially relevant for men [14]; however, even when symptoms were experienced 
some did not always link these to diabetic retinopathy but to an inevitable consequence of 
getting older [38]. 
 
Theme: Competing health problems (13 studies). Many people with diabetes experience 
competing health problems that can overshadow concerns with their eyes. For some, missing 
a screening appointment might be attributable to a temporary illness or health problem 
[24,25,28], but for others it was a consequence of comorbidities [26,43,53] or the burden of 
diabetes [18,30,40]. 
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Theme: Forgetting (10 studies). For some people with diabetes, failure to attend screening 
was attributed to: forgetting to make an appointment [26], forgetting to attend [25,27,54] or 
forgetting whether they had previously attended [15]. Several studies alluded to HCPs’ 
attempts to prompt or remind their patients in advance of their upcoming appointment [15,28] 
and some reported that reminders prompted them to maintain regular attendance [44]. 
 
Theme: Perception of people with diabetes that they have been checked elsewhere (five 
studies). Sometimes people believed they had been or were going to be checked elsewhere 
because they were transferring their eye care to another specialist [54], or their eyes had 
already been examined by a family physician or as part of routine eye test by an optician 
[28,37]. 
 
Theme: Knowing it’s a routine test (three studies). An enabler was expecting screening to be 
part of their routine care [31,32,55]. 
 
Beliefs about consequences (26 studies) 
Theme: Perceived necessity of screening (13 studies) and perception that screening provides 
valuable information on the health status of your eyes (seven studies). Some people with 
diabetes do not attend as they believe it is unnecessary [33,43,56]: 'I was told that my eyes 
are fine at my last screening' [15,26], 'my diabetes is under control' [14,38,47] and 
‘screening is not useful at my age’ [30,34]; however, others reported that screening will 
identify problems early and this was motivating [28,55,57,58]. Some reported that screening 
can provide reassurance that all is well [23,28,57] or that they attended screening as family 
members had experienced problems with diabetes or retinopathy in the past [28,31].  
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Themes: Short-term effects of screening (11 studies) and concerns about the harmful effect of 
the screening procedure (four studies). Some people with diabetes reported that screening has 
negative short-term effects, for example, some dislike mydriatic eye drops (given to 
temporarily dilate the pupils) [32,55,59], which were often uncomfortable or, in some cases, 
painful [28,30,38]. In one case a woman had developed a phobia of these eye drops [25]. 
 
Mydriatic drops were also inconvenient because of their temporary effects on vision; the 
individual was prohibited from driving until the effects of the drops had worn off or it was 
difficult to navigate public transport [28,32]. Some reported that screening could have long-
term negative effects on vision, either from the drops or from the retinal photographs [24,60]. 
 
Emotions (23 studies) 
Theme: Fear or anxiety (20 studies). For some, the fear of losing their vision was a strong 
incentive to attend screening [15,27,32], but, for others, fear of a diagnosis of diabetic 
retinopathy was a barrier [46,58,61] or fear of the screening procedure itself [25,30,48] or of 
a medical intervention if they were confronted with a diagnosis [30,42,62]. In one study, non-
adherent participants expressed less concern about losing their vision than adherent 
participants [63]. 
 
Theme: Defensive responses 
Defensive responses were sometimes noted. In one study, young adults who participated 
reported that they wanted to attend screening, but actively engaged in avoidance strategies 
[57]. In other studies people with diabetes simply refused to attend, without explanation 
[14,25,47]: '[the patient] is refusing to even discuss his condition, so all you can do is keep 
sending invites'
 
[25].  
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Theme: Emotional burden of diabetes. For some, attending screening appointments could 
exacerbate negative emotions relating to lack of control of their diabetes, including feelings 
of failure, guilt, fear and anger [15,27,46]. 
 
Details of the domains and the corresponding barriers/enablers that were considered less 
important are provided in Appendix S6. 
 
Discussion  
We used a systematic, theory-informed and replicable approach to identifying barriers and 
enablers associated with screening attendance. The combined content and framework analysis 
identified six Theoretical Domains Framework domains as the most influential factors in 
screening attendance: 1) ‘environmental context and resources’; 2) ‘social influences’; 3) 
‘knowledge’; 4) ‘memory, attention and decision processes’; 5) ‘beliefs about consequences’; 
and 6) ‘emotions’. Interventions that target these domains may be more likely to increase 
screening attendance. In contrast, three domains seemed to have the least influence on 
screening: 1) ‘optimism’; 2) ‘reinforcement’; and 3) ‘skills’. Hence, we propose that 
interventions targeting these three domains are less likely to increase screening attendance 
(Tables 2 and 3).  
 
Implications for practice  
Thematic synthesis within domains resulted in specific content themes that may help to 
identify potential targets for future Quality Improvement interventions. The content themes 
were identified at multiple levels, including: the person with diabetes (e.g. confusion between 
screening and routine eye care); the HCP (e.g. recommendation to screen, or lack of such 
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recommendation, by the HCP); the healthcare system (e.g. inaccurate registers); and the 
wider community (e.g. lack of media coverage; Appendix S6).  
 
Four key recommendations based on the findings from the thematic synthesis are: (1) to 
reduce inconvenience to people with diabetes; (2) to increase awareness of the importance of 
screening; (3) to increase a sense of comfort and support; and (4) to improve message 
content.  
 
1) Reduce inconvenience to people with diabetes 
Many of the barriers/enablers identified related to perceptions of convenience. Difficulties 
with transport, distance to the screening clinic, competing health and time demands, lack of 
instrumental/pragmatic support and scheduling appointment issues were reported to be 
important factors that may hinder attendance, whereas attempts to reduce inconvenience by 
improving accessibility, flexible appointments and integrating services were reported to 
facilitate attendance. Providing local screening facilities, ‘one-stop shops’ (integrating 
screening with other diabetes appointments), offering flexible appointment systems and 
childcare facilities, and providing transportation may therefore be advantageous. 
 
2) Increase awareness of the importance of screening  
Both people with diabetes and HCPs reported that a lack of awareness or understanding of 
diabetic retinopathy, diabetes and the link between the two was a barrier to attendance. 
Similarly, a lack of awareness of the importance of screening, the recommended frequency or 
a lack of targeted education were also reported to be barriers for people with diabetes, 
whereas providing blindness prevention programmes or general diabetes self-management 
education was reported to be an enabler. The perceived absence of an HCP recommendation 
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to attend screening and/or a lack of information provision from the HCP were also perceived 
barriers and therefore facilitating HCPs to provide such recommendations could potentially 
address this barrier. Similarly, using the local media and local community networks to 
improve awareness and promote attendance was reported as a potential but often untapped 
resource. 
 
3) Increase sense of comfort and support among people with diabetes 
Some reported barriers relating to difficulties with communicating with HCPs, a lack of trust 
in doctors, a lack of emotional support, and negative emotions (e.g. fear, worry). Although 
there were limited reports of potential enablers to overcome such barriers, there was some 
mention that community-based clinics, social/cultural compatibility between the person with 
diabetes and HCPs, and compassion from the HCP were enablers which might encourage 
feelings of comfort, support and trust. There is some evidence for additional benefits of using 
culturally competent interventions that are tailored to the needs of people from ethnic 
minority groups for improving diabetes-related outcomes [64]. 
 
4) Improve message content 
The absence of symptoms was a commonly mentioned barrier to attendance. Furthermore, 
some people with diabetes perceived that screening was not necessary, especially if they felt 
their diabetes was under control, they were not old, or if their previous test result was clear. It 
would seem desirable, therefore, to provide messages that highlight the asymptomatic nature 
of diabetic retinopathy and make salient the potential consequences if left unchecked. 
Likewise, providing messages that emphasize and highlight the benefits of early detection, 
the safety of the procedure and the reassurance a positive result can provide would be 
recommended and could help in part overcome barriers around emotional fears and concerns. 
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In addition, a barrier exists related to the confusion between attendance at diabetic 
retinopathy screening and routine eye tests. Messages highlighting the difference between the 
two and emphasizing the importance of continuing to attend despite attendance at other eye 
tests could be helpful. Furthermore, messages that emphasize that retinopathy screening is a 
routine part of diabetes care are also recommended, as this belief was identified as an enabler. 
The offer of a reminder to attend diabetic retinopathy screening was also regarded as an 
enabler addressing this domain. 
 
Recommendations for future research 
Identifying disparities in adherence to screening was not an objective of the present review 
and therefore it is not possible to recommend which sub-groups/populations require the 
greatest attention; however, a recent review has summarized the literature from the USA and 
highlighted disparities in a number of sub-groups including: males; youth- vs adult-onset 
diabetes; specific minority populations; and low socio-economic status [65]. Future research 
could endeavour to identify which theoretical domains are most important for people within 
these sub-groups. For example, we identified only two studies that explored factors impacting 
young adults [30,57]. This group is not only under-researched but also at high risk of vision 
loss/blindness from diabetic retinopathy. In one of these studies, Lake et al. [30] compared 
the barriers and enablers among young adults with Type 2 diabetes (age 18–39 years) with 
those among a group of older adults with Type 2 diabetes (age ≥40 years) and found that 
younger adults had a higher number of barriers compared with older adults, as well as factors 
that appeared to be highly relevant to younger adults such as ‘social comparison with others’, 
‘concerns for the impact on the family unit’, ‘unrealistic optimism’ and ‘perceived 
invulnerability’. Such knowledge will allow future interventions to be tailored to those most 
at risk.  
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Strengths, limitations and challenges 
The combination of deductive coding (informed by a theoretical framework to guide barrier 
identification) and inductive analysis (to allow more granular content themes, unanticipated 
findings and insights from people with diabetes to emerge) is a strength of this review. 
Furthermore, the review identified potential influence of people with diabetes, HCPs, 
organizational and contextual factors on screening attendance. We were able to code all 
extracted data from the 69 studies into theoretical domains, thus demonstrating that the 
framework provides a comprehensive coverage of barriers and enablers.  
 
Another strength was its inclusiveness. We included published and grey literature, qualitative 
and quantitative methodologies, perspectives of people with diabetes and HCPs’, and any 
context and/or screening model. Although not all barriers and enablers will be relevant to all 
settings, the present review gives a comprehensive overview of potential factors that may 
influence screening attendance.  
 
The studies in the present review predominantly identified barriers and enablers from the 
perspective of the person with diabetes rather than the perspective of the organization or 
HCP. Even the data we had from the HCPs mostly focused on their views regarding their 
patients' barriers.  
 
A number of the studies were poorly described. This hampered our ability to differentiate 
between the perspectives of the HCP and person with diabetes or to distinguish between 
different sub-groups of people with diabetes. Furthermore, the data extracted and analysed in 
the present review were those that were reported, analysed and interpreted by the study 
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authors. It is possible that our data set may have been biased, in that authors may have 
selectively reported findings on perceived barriers/enablers that were more prevalent, 
interesting, or had a better fit with the stated research question. A further limitation is that the 
theoretical framework used was restricted in that it did not specify relationships between 
domains and hence the likely strength of the direct impact of barriers on behaviour is not 
known. 
 
Although the majority of the title/abstract screening and quality appraisal was carried out by a 
single reviewer, there was excellent agreement on random subsets of studies that were 
checked by a second reviewer. Consequently, we do not believe that this constitutes a major 
limitation. 
 
Concluding remarks 
Six theoretical domains were identified as the factors most likely to be key mediators of 
retinopathy screening attendance behaviour. Interventions to increase screening attendance 
are more likely to be effective if they target these domains. Thematic synthesis identified key 
content themes that offer further insight into which specific issues need to be addressed 
[notably, accessibility of screening clinic, time (competing demands), financial concerns and 
scheduling appointment issues]. Future research is needed to identify which domains are 
most important for subgroups of people with diabetes that have been identified as most at 
risk.  
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Table 1 Characteristics of included studies 
Study characteristics Frequencies (total: 69 studies) 
Study methods 
45 (65%), quantitative (e.g. questionnaires, surveys) 
18 (26%), qualitative (e.g. interviews/focus groups) 
6 (9%), mixed methods 
Study location 
30 (43%), USA 
13 (19%), UK 
10 (14%), Asia 
6 (9%), Africa 
4 (6%), Australia 
3 (4%), Canada 
2 (3%), Europe  
1 (1.5%), South America 
Publication type 
56 (81%), full-text in peer-reviewed journals 
5 (7%), full-text in unpublished reports/dissertations 
8 (12%), abstracts/posters. 
Perspective of reported 
barrier/enabler 
53 (77%), perspective of people with diabetes 
15 (22%), both people with diabetes and HCP perspectives 
 
 n=11, specific ethnic groups (e.g. African American; American Indian; 
Aboriginal Canadian; people with South-Asian or Hispanic origin) 
 n=5, people who were classified as either non- or late-attenders 
 n=3, adults (e.g. age ≥40 years) 
 n=2, younger adults 
 n=2 (7%), women only 
 n= 2, people who had been diagnosed with diabetic retinopathy 
 n=1, participant receiving treatment 
 n=1, participants in a blindness prevention programme 
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 n=1, Medicare population  
 n=1, people with diabetes who were also hospital staff. 
HCP, healthcare professional. 
 
 
 
Table 2 Frequencies (number of themes/sub-themes) of barriers and enablers coded to each of the 14 
domains of the Theoretical Domains Framework 
 
  
Theoretical Domains Framework domain Barriers only Enablers only Both barriers and 
enablers 
Environmental context and resources 17 3 6 
Social influences 6 5 5 
Knowledge  4 5 6 
Memory attention and decision processes 9 3 0 
Beliefs about consequences 9 5 0 
Emotions 6 3 1 
Social professional role and identity 5 1 0 
Goals 2 1 1 
Beliefs about capabilities  2 0 0 
Behavioural regulation 0 2 1 
Intention 1 2 0 
Optimism  1 2 0 
Reinforcement 0 3 1 
Skills 0 0 0 
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Table 3 Frequency and elaboration within each of the 14 Theoretical Domains Framework domains, 
presented in rank order from most important to least important. 
 
 
Theoretical Domains Framework domain (rank 
order) 
Frequency Level of elaboration 
Number of 
studies 
identified 
Number of 
themes 
Number of 
sub-themes 
1. Environmental context and resources 52 11 23 
2. Social influences 35 11 8 
3. Knowledge  35 6 12 
4. Memory attention and decision processes 34 6 9 
5. Beliefs about consequences 26 9 10 
6. Emotions 23 6 6 
7. Goals  13 2 3 
8. Social professional role and identity  11 3 5 
9. Intention 9 2 4 
10. Beliefs about capabilities  9 1 2 
11. Behavioural regulation 7 3 0 
12. Optimism  5 3 0 
13. Reinforcement 3 2 4 
14. Skills 0 0 0 
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